ici 118551 has been researched along with Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denda, M; Fuziwara, S; Inoue, K | 1 |
Heijenbrok, FJ; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA | 1 |
2 other study(ies) available for ici 118551 and Hyperplasia
Article | Year |
---|---|
Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Clenbuterol; Epidermis; Humidity; Hyperplasia; Male; Mice; Mice, Hairless; Nifedipine; Procaterol; Propanolamines; Verapamil | 2003 |
Beta-adrenergic responses are significantly enhanced in rat carotid artery with intimal hyperplasia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carotid Artery Injuries; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Hyperplasia; Imidazoles; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Propanolamines; Rats; Rats, Wistar | 2000 |